Stocks and Investing
Stocks and Investing
Wed, June 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mark Massaro Maintained (wgs) at Strong Buy with Increased Target to $35 on, Jun 26th, 2024
Mark Massaro of BTIG, Maintained "GeneDx Holdings Corp." (WGS) at Strong Buy with Increased Target from $19 to $35 on, Jun 26th, 2024.
Mark has made no other calls on WGS in the last 4 months.
There are 2 other peers that have a rating on WGS. Out of the 2 peers that are also analyzing WGS, 1 agrees with Mark's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Sykes of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Monday, April 15th, 2024
This is the rating of the analyst that currently disagrees with Mark
- Dan Brennan of "TD Cowen" Maintained at Strong Buy with Increased Target to $24 on, Tuesday, April 30th, 2024
Contributing Sources